Newsroom

Keep up to date with the latest developments at CDISC and follow our news feeds!
CDISC and conect4children (c4c) release of Paediatrics User Guide to facilitate better medicines for babies, children and young people

CDISC and conect4children (c4c) release of Paediatrics User Guide to Facilitate Better Medicines for Babies, Children and Young People

Austin, TX and Newcastle upon Tyne, UK – 22 Feb 2023 – CDISC and conect4children (c4c) have announced the release of a Paediatrics User Guide, freely available on the CDISC website, to facilitate the development of medicines for children.

CDISC Welcomes New Chair and Members to Board of Directors
Austin, TX – 10 January 2023 – CDISC today announced three members have joined its Board of Directors: Jonathan Chainey, Dominic Labriola and Rhona O’Donnell each began serving a three-year term at the beginning of the year. Existing Member, Dr. Erik Pulkstenis, now leads the Board as Chair.
Veeva’s Dan Crawford Elected Chair of CDISC Advisory Council
AUSTIN, TX and PLEASANTON, CA — Dec. 14, 2022 — Veeva Systems (NYSE: VEEV) and CDISC are pleased to announce that Dan Crawford, Veeva Clinical Database (CDB) principal consultant, has been elected chair of the CDISC Advisory Council (CAC) . The CAC comprises representatives from CDISC platinum members who play an important role in shaping CDISC’s development and direction, providing the CDISC executive team with recommendations that support CDISC goals.
Clupea, KIT to establish Korea's 1st CDISC standard-based non-clinical big data…
SEND Virtual Meetings: Public Broadcast Hosted by FDA

CDISC invites you to an FDA-hosted public broadcast during the SEND Team’s fall virtual meetings. The broadcast is an opportunity for stakeholders to stay informed on what’s going on with the development of SEND and its use in regulatory submissions, as well as hear use cases from our global SEND user community.

Clinical trials haven’t harnessed the digital revolution — TransCelerate’s late…
EMA launches pilot project on analysis of raw data from clinical trials. Data s…
Harmonisation of large-scale, heterogeneous individual participant adverse even…
How TransCelerate, Microsoft, Accenture, and CDISC are Working to Revolutionize…
Embleema and CDISC Partner to Develop Standards for Cell and Gene Therapy Product Monitoring
METUCHEN, NJ and AUSTIN, TX – 24 May 2022 – Embleema Inc. and CDISC have announced a collaboration to develop new standards for experimental assays and bioinformatics protocols to facilitate monitoring the activity of Cell and Gene Therapy Products (CGTP).